LipoP

LipoP predicts lipoprotein signal peptides in Gram-negative bacteria and can be applied to Gram-positive organisms to differentiate SPaseII-cleaved lipoproteins, SPaseI-cleaved proteins, cytoplasmic proteins, and transmembrane proteins.

Key Features:

• Signal peptide classification: Distinguishes SPaseII-cleaved lipoproteins, SPaseI-cleaved proteins, cytoplasmic proteins, and transmembrane proteins.
• HMM-based modeling: Employs a hidden Markov model to model sequence patterns associated with lipoprotein signal peptides.
• High accuracy: Correctly identifies 96.8% of lipoproteins with a false positive rate of 0.3% in reported test sets.
• Gram-positive applicability: Demonstrates applicability to Gram-positive bacteria with 92.9% accuracy on relevant test sets.
• Neural network alternative: Includes a neural network–based predictor developed for comparison that yielded very similar predictive outcomes.
• Experimental validation: Predictions have been validated against experimental data, including experimentally verified lipoproteins in Escherichia coli K12.
• Genome-wide search capability: Has been employed in genome searches across 12 Gram-negative genomes and one Gram-positive genome.

Scientific Applications:

• Protein targeting and secretion studies: Facilitates analysis of bacterial protein targeting and secretion systems by identifying lipoprotein signal peptides.
• Protein localization and function inference: Aids inference of protein localization and potential function within bacterial cells.
• Antimicrobial target identification: Supports identification of potential targets for antimicrobial strategies by revealing critical lipoprotein components of bacterial physiology.

Methodology:

LipoP applies a hidden Markov model to analyze sequences and predict lipoprotein signal peptides and additionally incorporates a neural network–based predictor for comparative predictions.